Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome

Marie-Christine Alessi, Christophe Gaudin, Philippe Grosjean, Valérie Martin, Serge Timsit, Marie-Hélène Mahagne, Vincent Larrue, Igor Sibon, Mathieu Zuber, Raf Brouns, Joan Montaner, Mar Castellanos, Yves Donazzolo, Tae-Hee Cho, Laurent Suissa, Laura Mechtouff, Laurent Derex, Pierre Suchon, Anna Mezzapesa, Norbert Nighoghossian
Cerebrovasc Dis. 2016-01-01; 42(5-6): 404-414
DOI: 10.1159/000447722


Auteurs Bordeaux Neurocampus